Find » Health & Wellness » BSP Pharma Inc. Announces Groundbre...

BSP Pharma Inc. Announces Groundbreaking Findings from the Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study

Rating: 3.0 of 5
By MultiVu Video, published Dec 03, 2007
Research has indicated that FlexNow® Joint Formula shows significant reductions in cartilage deterioration, joint inflammation, and joint pain.

BSP Pharma Inc., the maker and distributor of FlexNow® Joint Formula, has announced the findings from the new joint health clinical study completed this past June at the Australian Centre for Complementary Medicine Education and Research (ACCMER) in Brisbane, Australia led by Dr. Phillip Cheras PhD.

Results show that, for those with elevated cartilage deterioration in their joints, FlexNow Joint Formula provides an unprecedented reduction in cartilage deterioration for a natural product, 44% higher than that reported for glucosamine.1 . This is the first human clinical study of a natural product showing such a great reduction in a well recognised marker for cartilage deterioration as well as significant reductions in joint specific inflammation and joint pain.

Credit: MultiVu
Copyright: MultiVu
MultiVu Video
Published Content: 288
Total Views: 6,791
Favorited By: 0
Comments
Type in Your Comments Below - (1000 characters left)
Your name:

Submit your own content on this or any topic. Get started »
Advertisment